Stablecoin Development Corp.
AMEX: SDEV0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- New York Stock Exchange American
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Michael Kazley
- Employees
- 4
- Headquarters
- Emeryville, United States
- IPO year
- 2026
- Market cap
- $33.6M
- Website
- http://www.novabay.com
Loading SDEV…
Loading profile data…Frequently asked questions about SDEV
What does Stablecoin Development Corp. (SDEV) do?
Stablecoin Development Corp. specializes in manufacturing and distributing eye and skin health solutions that have undergone rigorous scientific development and proven efficacy in clinical settings. Their product portfolio features prominent brands such as Avenova, NeutroPhase, and DERMAdoctor. This enterprise was established on January 19, 2000...
Where does SDEV trade?
Stablecoin Development Corp. (SDEV) trades on the New York Stock Exchange American.
What sector is SDEV in?
Stablecoin Development Corp. (SDEV) operates in the Healthcare sector, specifically in the Medical - Pharmaceuticals industry.
Who is the CEO of Stablecoin Development Corp.?
Michael Kazley is the chief executive officer of Stablecoin Development Corp. (SDEV).
Where is Stablecoin Development Corp. headquartered?
Stablecoin Development Corp. is headquartered in United States.
Does SDEV pay a dividend?
Yes — Stablecoin Development Corp. (SDEV) paid a trailing twelve-month dividend of USD 4.00 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did SDEV go public?
Stablecoin Development Corp. (SDEV) completed its initial public offering in 2026.